PSEN2 and Alzheimer disease: To screen for potential AD therapeutic targets it is important to consider cell states that are disease-relevant, and so we chose to use mouse BV2 microglia cell lines in which the Psen2 gene is stably knocked down by shRNA (i.e. psen2_kd) along with a control line (i.e. scramble).